Related Experiment Videos

The era of the device in ischemic stroke

Helmi L Lutsep¹

¹Oregon Stroke Center, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, CR 131, Portland, OR 97201, USA. lutseph@ohsu.edu

Current Neurology and Neuroscience Reports

|June 26, 2004

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Safety and efficacy of factor XIa inhibition with milvexian for secondary stroke prevention (AXIOMATIC-SSP): a phase 2, international, randomised, double-blind, placebo-controlled, dose-finding trial.

The Lancet. Neurology·2023

Endovascular Therapy for Basilar Artery Occlusion: Among the First to Conceptualize, Last to Prove.

Stroke·2023

Rationale and design of the AXIOMATIC-SSP phase II trial: Antithrombotic treatment with factor XIa inhibition to Optimize Management of Acute Thromboembolic events for Secondary Stroke Prevention.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2022

Global Impact of COVID-19 on Stroke Care and IV Thrombolysis.

Neurology·2021

Global impact of COVID-19 on stroke care.

International journal of stroke : official journal of the International Stroke Society·2021

Prevalence of Retinal Emboli and Acute Retinal Artery Occlusion in Acute Ischemic Stroke.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2019

See all related articles